The Role of Peroxisome Proliferator-Activated Receptor γ in Mediating Cardioprotection Against Ischemia/Reperfusion Injury

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Cardiovascular Pharmacology and Therapeutics

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/1074248417707049PMID 28466688
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The high-fat diet induces myocardial fibrosis in the metabolically healthy obese minipigs-The role of ER stress and oxidative stress.

  2017cited by this paper
• Fatty acids, eicosanoids and PPAR gamma.

  2016cited by this paper
• Nanoparticle-Mediated Delivery of Irbesartan Induces Cardioprotection from Myocardial Ischemia-Reperfusion Injury by Antagonizing Monocyte-Mediated Inflammation

  2016influential reference
• Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association

  2016cited by this paper
• Inflammation and Inflammatory Cells in Myocardial Infarction and Reperfusion Injury: A Double-Edged Sword

  2016cited by this paper
• Mechanism of TLR-4/NF-κB pathway in myocardial ischemia reperfusion injury of mouse.

  2016cited by this paper
• The Role of Oxidative Stress in Myocardial Ischemia and Reperfusion Injury and Remodeling: Revisited

  2016cited by this paper
• IL-23 Promotes Myocardial I/R Injury by Increasing the Inflammatory Responses and Oxidative Stress Reactions

  2016cited by this paper
• Peroxisome proliferator-activated receptors (PPARα, PPARγ and PPARβ/δ) gene expression profile on ram spermatozoa and their relation to the sperm motility

  2016cited by this paper
• Clinical effects of cyclosporine A on reperfusion injury in myocardial infarction: a meta-analysis of randomized controlled trials

  2016cited by this paper
• Mutual Regulation of Epicardial Adipose Tissue and Myocardial Redox State by PPAR-γ/Adiponectin Signalling

  2016influential reference
• Aleglitazar, a Balanced Dual PPARα and -γ Agonist, Protects the Heart Against Ischemia-Reperfusion Injury

  2016cited by this paper
• Various peroxisome proliferator‐activated receptor (PPAR)‐γ agonists differently induce differentiation of cultured human keratinocytes

  2015cited by this paper
• Ca2+ Sparks and Ca2+ waves are the subcellular events underlying Ca2+ overload during ischemia and reperfusion in perfused intact hearts.

  2015cited by this paper
• TNF-α antagonism ameliorates myocardial ischemia-reperfusion injury in mice by upregulating adiponectin.

  2015cited by this paper
• Mitochondrial JNK activation triggers autophagy and apoptosis and aggravates myocardial injury following ischemia/reperfusion.

  2015cited by this paper
• Neutrophil extracellular traps in ischemia-reperfusion injury-induced myocardial no-reflow: therapeutic potential of DNase-based reperfusion strategy.

  2015cited by this paper
• Reducing myocardial infarct size: challenges and future opportunities

  2015cited by this paper
• Protective Effect of Sevoflurane Postconditioning against Cardiac Ischemia/Reperfusion Injury via Ameliorating Mitochondrial Impairment, Oxidative Stress and Rescuing Autophagic Clearance

  2015cited by this paper
• Pharmacological activation of PPAR gamma ameliorates vascular endothelial insulin resistance via a non-canonical PPAR gamma-dependent nuclear factor-kappa B trans-repression pathway.

  2015cited by this paper
• Impaired fatty acid oxidation as a cause for lipotoxicity in cardiomyocytes.

  2015cited by this paper
• Activation of Peroxisome Proliferator-Activated Receptor γ (PPARγ) Through NF-κB/Brg1 and TGF-ß1 Pathways Attenuates Cardiac Remodeling in Pressure-Overloaded Rat Hearts

  2015cited by this paper
• Carbon monoxide increases inducible NOS expression that mediates CO-induced myocardial damage during ischemia-reperfusion.

  2015cited by this paper
• Novel therapeutics in myocardial infarction: targeting microvascular dysfunction and reperfusion injury.

  2015influential reference
• Conditional Deletion of Cardiomyocyte Peroxisome Proliferator-Activated Receptor &ggr; Enhances Myocardial Ischemia-Reperfusion Injury in Mice

  2014cited by this paper
• Hydroxyoctadecadienoic Acids Regulate Apoptosis in Human THP-1 Cells in a PPARγ-Dependent Manner

  2014cited by this paper
• A systems biology approach to understand the pathophysiological mechanisms of cardiac pathological hypertrophy associated with rosiglitazone

  2014cited by this paper
• Sequestration of fatty acids in triglycerides prevents endoplasmic reticulum stress in an in vitro model of cardiomyocyte lipotoxicity.

  2014cited by this paper
• Comparison of statin alone versus bezafibrate and statin combination in patients with diabetes mellitus and acute coronary syndrome.

  2014cited by this paper
• PPAR ligands improve impaired metabolic pathways in fetal hearts of diabetic rats.

  2014cited by this paper
• Panax Quinquefolium Saponin Attenuates Cardiomyocyte Apoptosis and Opening of the Mitochondrial Permeability Transition Pore in a Rat Model of Ischemia/Reperfusion

  2014cited by this paper
• Cardiovascular remodelling in coronary artery disease and heart failure.

  2014cited by this paper
• Rabbit Sera Containing Compound Danshen Dripping Pill Attenuate Leukocytes Adhesion to TNF-Alpha–Activated Human Umbilical Vein Endothelial Cells by Suppressing Endothelial ICAM-1 and VCAM-1 Expression Through NF-KappaB Signaling Pathway

  2014cited by this paper
• Adiponectin regulates SR Ca(2+) cycling following ischemia/reperfusion via sphingosine 1-phosphate-CaMKII signaling in mice.

  2014cited by this paper
• Systemic metabolic markers and myocardial glucose uptake in type 2 diabetic and coronary artery disease patients treated for 16 weeks with rosiglitazone, a PPARγ agonist

  2014cited by this paper
• Pioglitazone inhibits high glucose-induced expression of receptor for advanced glycation end products in coronary artery smooth muscle cells

  2014cited by this paper
• Rosiglitazone causes cardiotoxicity via peroxisome proliferator-activated receptor γ-independent mitochondrial oxidative stress in mouse hearts.

  2014cited by this paper
• Generation of an inducible, cardiomyocyte-specific transgenic mouse model with PPAR β/δ overexpression.

  2013cited by this paper
• Interactions Between Vascular Wall and Perivascular Adipose Tissue Reveal Novel Roles for Adiponectin in the Regulation of Endothelial Nitric Oxide Synthase Function in Human Vessels

  2013cited by this paper
• Telmisartan protects against microvascular dysfunction during myocardial ischemia/reperfusion injury by activation of peroxisome proliferator-activated receptor gamma

  2013influential reference
• Myocardial capillary density in normal and diabetic male rats: Effect of bezafibrate

  2013cited by this paper
• Peroxisome proliferator-activated receptors modulate cardiac dysfunction in diabetic cardiomyopathy.

  2013cited by this paper
• Myocardial structure, function and ischaemic tolerance in a rodent model of obesity with insulin resistance

  2013cited by this paper
• Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice

  2013cited by this paper
• AMPK-Regulated and Akt-Dependent Enhancement of Glucose Uptake Is Essential in Ischemic Preconditioning-Alleviated Reperfusion Injury

  2013cited by this paper
• PPARγ signaling and metabolism: the good, the bad and the future

  2013cited by this paper
• Apoptosis and autophagy contribute to gender difference in cardiac ischemia-reperfusion induced injury in rats.

  2013cited by this paper
• Activation of Receptors δ (PPARδ) by Agonist (GW0742) may Enhance Lipid Metabolism in Heart both In Vivo and In Vitro

  2013cited by this paper
• [Influence of siRNA-mediated PPARgamma gene knockdown on insulin resistance induced by myocardial ischemia-reperfusion in rats].

  2013cited by this paper
• Intervention of rosiglitazone on myocardium Glut-4 mRNA expression during ischemia–reperfusion injury in cardio-pulmonary bypass in dogs

  2012cited by this paper
• Identification, organ expression and ligand-dependent expression levels of peroxisome proliferator activated receptors in grass carp (Ctenopharyngodon idella).

  2012cited by this paper
• The PPARγ Agonist Protects Cardiomyocytes from Oxidative Stress and Apoptosis via Thioredoxin Overexpression

  2012cited by this paper
• In Vitro and In Vivo Characterizations of Chiglitazar, a Newly Identified PPAR Pan-Agonist

  2012cited by this paper
• Insulin Resistance and Metabolic Derangements in Obese Mice Are Ameliorated by a Novel Peroxisome Proliferator-activated Receptor γ-sparing Thiazolidinedione*

  2012cited by this paper
• Adiponectin elevation by telmisartan ameliorates ischaemic myocardium in zucker diabetic fatty rats with metabolic syndrome

  2012cited by this paper
• Pioglitazone attenuates myocardial ischemia-reperfusion injury via up-regulation of ERK and COX-2.

  2012cited by this paper
• Myocardial fatty acid metabolism and lipotoxicity in the setting of insulin resistance.

  2012cited by this paper
• Protective Effects of Peroxiredoxin on Hydrogen Peroxide Induced Oxidative Stress and Apoptosis in Cardiomyocytes

  2012cited by this paper
• Ovary-specific novel peroxisome proliferator activated receptors-gamma transcripts in buffalo.

  2012cited by this paper
• ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1

  2011cited by this paper
• Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-γ-independent manner

  2011influential reference
• Antioxidant properties of pioglitazone limit nicotinamide adenine dinucleotide phosphate hydrogen oxidase and augment superoxide dismutase activity in cardiac allotransplantation.

  2011cited by this paper
• The role of PPAR in myocardial response to ischemia in normal and diseased heart.

  2011cited by this paper
• Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice.

  2011cited by this paper
• Effect of pretreatment with pioglitazone on reperfusion injury in diabetic patients with acute myocardial infarction.

  2011cited by this paper
• Role of nuclear factor kappaB in cardiovascular health and disease.

  2010cited by this paper
• Regulation of IκBα Function and NF-κB Signaling: AEBP1 Is a Novel Proinflammatory Mediator in Macrophages

  2010cited by this paper
• Signaling and cytotoxic functions of 4-hydroxyalkenals.

  2010cited by this paper
• PPARs: Nuclear Receptors Controlled by, and Controlling, Nutrient Handling through Nuclear and Cytosolic Signaling

  2010influential reference
• Peroxisome proliferator-activated receptors gamma and alpha agonists stimulate cardiac glucose uptake via activation of AMP-activated protein kinase.

  2010cited by this paper
• Ligand Modulated Antagonism of PPARγ by Genomic and Non-Genomic Actions of PPARδ

  2009cited by this paper
• Antidiabetic drug pioglitazone protects the heart via activation of PPAR-gamma receptors, PI3-kinase, Akt, and eNOS pathway in a rabbit model of myocardial infarction.

  2009influential reference
• Hypothermia attenuates ischemia/reperfusion‐induced endothelial cell apoptosis via alterations in apoptotic pathways and JNK signaling

  2009cited by this paper
• Restraint stress induces lymphocyte reduction through p53 and PI3K/NF-kappaB pathways.

  2008cited by this paper
• Effect of GCP-02, a PPARalpha/gamma dual activator, on glucose and lipid metabolism in insulin-resistant mice.

  2008cited by this paper
• Up‐regulation of PPARγ in myocardial infarction

  2008cited by this paper
• Up-regulation of PPARgamma in myocardial infarction.

  2008cited by this paper
• Cardiac Glucose Uptake and Suppressed Expression/Translocation of Myocardium Glucose Transport-4 in Dogs Undergoing Ischemia-Reperfusion

  2008cited by this paper
• Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.

  2007cited by this paper
• Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets.

  2007cited by this paper
• DIVERSE CARDIOPROTECTIVE SIGNALING MECHANISMS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-γ LIGANDS, 15-DEOXY-Δ12,14-PROSTAGLANDIN J2 AND CIGLITAZONE, IN REPERFUSION INJURY: ROLE OF NUCLEAR FACTOR-κB, HEAT SHOCK FACTOR 1, AND AKT

  2007cited by this paper
• The effects of obesity-associated insulin resistance on mRNA expression of peroxisome proliferator-activated receptor-γ target genes, in dogs

  2007cited by this paper
• Myocardial reperfusion injury.

  2007cited by this paper
• Rosiglitazone Reduces Glucose-Induced Oxidative Stress Mediated by NAD(P)H Oxidase via AMPK-Dependent Mechanism

  2007cited by this paper
• PPARs and molecular mechanisms of transrepression.

  2007influential reference
• Potential Effects of Angiotensin II Receptor Blockers on Glucose Tolerance and Adiponectin Levels in Hypertensive Patients

  2007cited by this paper
• Cardiac peroxisome proliferator-activated receptor gamma is essential in protecting cardiomyocytes from oxidative damage.

  2007cited by this paper
• PPAR agonists: multimodal drugs for the treatment of type-2 diabetes.

  2007influential reference
• Myocardial Ischemia/Reperfusion Injury and Infarct Size in Vivo

  2006cited by this paper
• Pioglitazone but Not Glibenclamide Improves Cardiac Expression of Heat Shock Protein 72 and Tolerance Against Ischemia/Reperfusion Injury in the Heredity Insulin-Resistant Rat

  2006cited by this paper
• Peroxisome proliferator-activated receptor gamma in malignant diseases.

  2006cited by this paper
• New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).

  2006influential reference
• Peroxisome proliferator-activated receptor in malignant diseases

  2006cited by this paper
• PPAR-γ activation fails to provide myocardial protection in ischemia and reperfusion in pigs

  2005cited by this paper
• PPAR-gamma activation fails to provide myocardial protection in ischemia and reperfusion in pigs.

  2005cited by this paper
• Rosiglitazone treatment in Zucker diabetic Fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia/reperfusion-induced myocardial injury.

  2005cited by this paper
• PPARγ activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes

  2004cited by this paper
• The STAT3 DNA-binding domain mediates interaction with NF-kappaB p65 and inducible nitric oxide synthase transrepression in mesangial cells.

  2004cited by this paper
• Prostaglandin E2 Protects the Heart From Ischemia-Reperfusion Injury via Its Receptor Subtype EP4

  2004cited by this paper
• Sucrose-induced cardiomyocyte dysfunction is both preventable and reversible with clinically relevant treatments.

  2004influential reference

• β-Sitosterol suppresses NLRP3 Inflammasome activation and Pyroptosis in myocardial ischemia/reperfusion injury via inhibition of PPARγ2.

  2025cites this paper
• Cyclic azapeptide cluster of differentiation-36 receptor modulator attenuates left ventricular injury and temporarily reduces long-chain fatty acid accumulation after myocardial ischemia-reperfusion in mice

  2025cites this paper
• Ginsenoside Rg5 Improves Radiation‐Induced Heart Injury via PPARG/PDK1/AKT1 Pathway

  2025cites this paper
• CB2 Cannabinoid Receptor as a Potential Target in Myocardial Infarction: Exploration of Molecular Pathogenesis and Therapeutic Strategies

  2024cites this paper
• Effects of scutellarin on acute myocardial ischemia/reperfusion injury in isolated rat heart

  2023cites this paper
• Effect of Cold Adaptation on the State of Cardiovascular System and Cardiac Tolerance to Ischemia/Reperfusion Injury

  2023cites this paper
• A bibliometric analysis of cardiomyocyte apoptosis from 2014 to 2023: A review

  2023cites this paper
• The role of PPARγ in intermittent hypoxia-related human umbilical vein endothelial cell injury

  2022cites this paper
• Cardioprotective effect of Cinnamomum zeylanicum extract on rats fed on high fat high fructose diet

  2022cites this paper
• Didymin Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the PPAR Signaling Pathway

  2022cites this paper
• Role of Oxidative Stress in Cardiac Dysfunction and Subcellular Defects Due to Ischemia-Reperfusion Injury

  2022cites this paper
• Untangling the Cooperative Role of Nuclear Receptors in Cardiovascular Physiology and Disease

  2021cites this paper
• Interaction of Obesity and Hypertension on Cardiac Metabolic Remodeling and Survival Following Myocardial Infarction

  2021cites this paper
• Macrophage Activities in Myocardial Infarction and Heart Failure

  2020cites this paper
• Propofol ameliorates endotoxin-induced myocardial cell injury by inhibiting inflammation and apoptosis via the PPARγ/HMGB1/NLRP3 axis

  2020cites this paper
• Ficus carica L. Attenuates Denervated Skeletal Muscle Atrophy via PPARα/NF-κB Pathway

  2020cites this paper
• Chrysin rescues rat myocardium from ischemia-reperfusion injury via PPAR-γ/Nrf2 activation.

  2020cites this paper
• Cardioprotective effect of pioglitazone and curcumin against diabetic cardiomyopathy in type 1 diabetes mellitus: impact on CaMKII/NF-κB/TGF-β1 and PPAR-γ signaling pathway

  2020cites this paper
• Cardioprotective effect of pioglitazone and curcumin against diabetic cardiomyopathy in type 1 diabetes mellitus: impact on CaMKII/NF-κB/TGF-β1 and PPAR-γ signaling pathway

  2020cites this paper
• The Role of Natriuretic Peptides in the Regulation of Cardiac Tolerance to Ischemia/Reperfusion and Postinfarction Heart Remodeling

  2020cites this paper
• Carbon monoxide–releasing molecule-3: Amelioration of renal ischemia reperfusion injury in a rat model

  2020cites this paper
• PPARγ activation mitigates mechanical allodynia in paclitaxel-induced neuropathic pain via induction of Nrf2/HO-1 signaling pathway.

  2020cites this paper
• Long non-coding RNA NEAT1 modulates hypoxia/reoxygenation-induced cardiomyocyte injury via targeting microRNA-520a.

  2019cites this paper
• Long non ‐ coding RNA NEAT 1 modulates hypoxia / reoxygenation ‐ induced cardiomyocyte injury via targeting microRNA ‐ 520 a

  2019cites this paper
• Dragon's Blood exerts cardio-protection against myocardial injury through PI3K-AKT-mTOR signaling pathway in acute myocardial infarction mice model.

  2018cites this paper
• Biochemical targets of drugs mitigating oxidative stress via redox-independent mechanisms.

  2017cites this paper